(Alliance News) - Yourgene Health PLC on Friday announced that its takeover by Novacyt SA, a biotechnology group focused on clinical diagnostics, is complete. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - FTSE Russell on Friday announced a number of deletion changes in the FTSE UK Index series. Read More
Yourgene Health PLC - Manchester, England-based molecular diagnostics group - Reports court-sanctioned scheme of arrangement to facilitate takeover by Novacyt SA has been approved by shareholders at a court and general meeting. Around 99% of shareholders who voted were in favour of the scheme. Takeover now requires the scheme of arrangement to be court sanctioned. These timings will be provided in due course. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
Yourgene Health PLC - Manchester, England-based molecular diagnostics group - Signs five-year contract extension with Illumina Inc. The contract is a restated licence and supply agreement for Yourgene's sequencing based NIPT in vitro diagnostic products, which will now run until September 2028. Says the license allows it to continue its product development roadmaps, as it looks to further move into "key international markets, such as the Americas, UK, Europe and Australia. Read More
(Alliance News) - European equities went into Monday afternoon on the up, with the FTSE 100 outperforming as it was supported by its natural resources sector and oil majors. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday. Read More
(Alliance News) - Yourgene Health PLC on Monday said it has agreed to a cash takeover offer from Novacyt SA that values Yourgene about GBP17 million. Read More
(Alliance News) - European markets rose at Monday's open, kicking off the start of the second half on a positive note, boosted by strong trading in Asia and New York, Read More
(Alliance News) - Yourgene Health PLC on Tuesday said it will sell its subsidiary Yourgene Health Taiwan Co Ltd to INEX Innovate Pte Ltd for up to USD4 million Read More
(Alliance News) - Yourgene Health PLC on Monday said that is due to process diagnostic tests at its laboratory in Manchester, as part of a deal signed by its partner, MyHealthChecked PLC, with Boots UK Ltd. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - Yourgene Health PLC said on Friday Chief Financial Officer Barry Hextall was resigning as a director with immediate effect. Read More
(Alliance News) - The following is a round-up of updates on exposure to Silicon Valley Bank by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
Yourgene Health PLC - Manchester-based molecular diagnostics - Bill Chang, the company's "chief entrepreneur", buys 13.9 million shares at 0.37 pence and 0.43p, worth GBP59,304, on Friday last week and Tuesday this week. Now has 302.9 million shares, a 9.5% stake. Read More
Intuitive Investments Group PLC - London-based life sciences investor - Buys 50 million shares at 0.3 pence per share of Manchester-based molecular diagnostics company Yourgene Health PLC, totalling GBP150,407. Intuitive holds 51.6 million shares of Yourgene. Read More
Yourgene Health PLC - Manchester-based molecular diagnostics - Says that its retail offer that was conducted through a bookbuild is now closed. Plans to confirm the results following the conclusion of the general meeting on January 9 at 1600 GMT. Read More
Yourgene Health PLC - Manchester-based molecular diagnostics - Raises GBP6.4 million from placing and subscription of 2.14 billion new shares at 0.30 pence each. The share offer, first announced late on Wednesday, was run as an accelerated book build by Singer Capital Markets. Also plans retail share offer at same price to raise up to GBP1.0 million. Calls general meeting for January 9 to approve the capital raise, whose proceeds will be used for near-term working capital and to pay for restructuring aimed at delivering cost savings. Yourgene Health directors subscribed for 383.3 million of the new shares. Read More